Govindan Discusses the Phase I Results of AMG 510 Evaluated in NSCLC

​​​​​​​Ramaswamy Govindan, MD, professor of medicine, Washington University School of Medicine discusses the results of a phase 1 study looking at safety, tolerability, pharmacokinetics, and efficacy of KRAS G12C inhibitor, AMG 510 in patients with non-small cell lung cancer.